Latest News

Latest news from the IPHA and the international research-based pharmaceutical industry in Ireland and globally. You may subscribe to the Latest News RSS Feed here.

 
IPHA responds to ESRI report on use of pharmaceuticals (01/25/2012)
The Irish Pharmaceutical Healthcare Association (IPHA) has responded to the HSE commissioned report by the ESRI, Delivery of Pharmaceuticals in Ireland – Getting a Bigger Bang for the Buck.
Revised Code of Marketing Practice for the Pharmaceutical Industry (Edition 7.5) (01/10/2012)
Benefits of pharmaceutical innovation far exceed health costs (12/01/2011)
Benefits of pharmaceutical innovation far exceed health costs Longevity and economic growth go hand in hand with innovation in the research-based pharmaceutical industry, according to Professor Frank Lichtenberg, of the Columbia Graduate School of Business, Columbia University, New York.
IPHA response to ESRI Budget Perspectives (2012) (10/14/2011)
The supply of medicines to the health services by pharmaceutical companies has been governed by a series of agreements between the State and the Irish Pharmaceutical Healthcare Association (IPHA), on behalf of the international research-based pharmaceutical industry. The current agreement was implemented in September 2006 and will run until March 2012. During its time, it is estimated that it will have delivered savings to the State of over €300 million.
New Member Elected to the Board of the Irish Pharmaceutical Healthcare Association (09/28/2011)
The Irish Pharmaceutical Healthcare Association (IPHA) is pleased to announce the election of Dr. David Hall PhD MEng MBA to the Board of Directors of the Association.
Latest CD–ROM edition of medicines.ie launched (08/22/2011)
The Irish Pharmaceutical Healthcare Association (IPHA) has launched the 2011/2012 version of its highly successful medicines.ie CD-ROM.
MMI Clinical & Translational Research Scholars Programme Launch (03/08/2011)
MMI Clinical & Translational Research Scholars Programme – Applications Invited A unique cross-institutional PhD programme, integrated with industry and clinical research centres, which will prepare graduates for careers in industry, academic medical centres and as biomedical entrepreneurs.
IPHA launches medicines.ie on facebook - first time such information on Irish medicines available there (03/07/2011)
Almost one million individual visitors used medicines.ie to find out about medicines information in 2010. This morning IPHA launched medicines.ie on facebook. This means that independently approved, high quality information on medicines in Ireland is now available on facebook for the first time.
Dr Neil Boyle appointed as Vice-President of the Irish Pharmaceutical Healthcare Association (12/20/2010)
The Irish Pharmaceutical Healthcare Association (IPHA) is pleased to announce the election of Dr Neil Boyle MB BCh BAO Dip. Pharm. Med. FFPM RCP (UK) as Vice-President of the Association. A native of Sligo, Neil attended the National University of Ireland Galway where he graduated with an honours degree in medicine in 1989. He worked in Clinical Medicine from 1989 to 1992 and spent his last year as Medical Registrar in Sligo General Hospital.
IPHA response to the article “APMI in Dáil claims over generic drugs” in the Irish Medical Times, 16th December 2010 (12/16/2010)
The Irish Pharmaceutical Healthcare Association (IPHA) wishes to respond to the article “APMI in Dáil claims over generic drugs” which appeared on the IMT website (www.imt.ie) on the 14th December 2010 and subsequently in the Irish Medical Times newspaper on the 16th December 2010. In the article it is stated that “there has been no engagement” by IPHA with the APMI. This is inaccurate. The IPHA received a complaint from APMI against the activities of the Irish Osteoporosis Society dated the 1st December 2010.
 

Related Content

Petri dishes
IPHA Press Releases 

IPHA is a member of -

IFPMAAESGPEFPIA

For medicines and clinical trials information visit -

medicines.ieself-care.ieIFPMA Portal